Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
India’s cheap-urea model faces an expensive reckoning
India faces rising fertilizer costs, prompting a review of its subsidy system. Global supply chain issues and war have doubled procurement expenses for the nation.
PCB crunch, US tariffs shrink Q1 electronic component exports
First-quarter electronic component exports shrank 16% year-on-year to $1.34 billion, while overall electronic goods exports increased 22.5%, latest data from the commerce department showed.
Inflation seen easing further to 15.51% in July
BusinessDay’s economists project that Nigeria’s headline inflation will ease to 15.51 percent in July, dropping from the 15.91 percent recorded read more Inflation seen easing further to 15.51% in…
Japan’s inflation paradox is creating winners and losers
The rising cost of living is challenging Takaichi's triumphant rhetoric about Japan's economy, as inflation causes pain for many, while also ushering in an era of renewed dynamism.
Govt rejects petroleum dealers’ monthly pricing demand
https://www.dawn.com/news/2022658